Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review

dc.contributor.authorEvelyn Meléndrez-Balcázar
dc.contributor.authorKarla Aranda-Vela
dc.contributor.authorAlberto Cervantes-Hernández
dc.contributor.authorSamuel López-Cureño
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:03:48Z
dc.date.available2026-03-22T21:03:48Z
dc.date.issued2024
dc.descriptionCitaciones: 8
dc.identifier.doi10.1053/j.ajkd.2024.01.527
dc.identifier.urihttps://doi.org/10.1053/j.ajkd.2024.01.527
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85708
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofAmerican Journal of Kidney Diseases
dc.sourceUniversidad La Salle
dc.subjectMedicine
dc.subjectTransthyretin
dc.subjectAmyloidosis
dc.subjectRenal function
dc.subjectFunction (biology)
dc.subjectInternal medicine
dc.titleHereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review
dc.typereview

Files